Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Medicinal plants against hepatitis C virus.

Ashfaq UA, Idrees S.

World J Gastroenterol. 2014 Mar 21;20(11):2941-7. doi: 10.3748/wjg.v20.i11.2941. Review.

2.

Hepatitis C virus and natural compounds: a new antiviral approach?

Calland N, Dubuisson J, Rouillé Y, Séron K.

Viruses. 2012 Oct 17;4(10):2197-217. doi: 10.3390/v4102197. Review.

3.

Antiviral activities of Indonesian medicinal plants in the East Java region against hepatitis C virus.

Wahyuni TS, Tumewu L, Permanasari AA, Apriani E, Adianti M, Rahman A, Widyawaruyanti A, Lusida MI, Fuad A, Soetjipto, Nasronudin, Fuchino H, Kawahara N, Shoji I, Deng L, Aoki C, Hotta H.

Virol J. 2013 Aug 13;10:259. doi: 10.1186/1743-422X-10-259.

4.

Hepatitis C virus NS3 inhibitors: current and future perspectives.

Salam KA, Akimitsu N.

Biomed Res Int. 2013;2013:467869. doi: 10.1155/2013/467869. Epub 2013 Oct 27. Review.

5.

Recent advance in antiviral drugs for hepatitis C.

Liu J, Shi S, Zhuang H, Luo G.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2011 Nov;36(11):1025-36. doi: 10.3969/j.issn.1672-7347.2011.11.001. Review.

6.

The efficacy and safety of telaprevir - a new protease inhibitor against hepatitis C virus.

Gentile I, Carleo MA, Borgia F, Castaldo G, Borgia G.

Expert Opin Investig Drugs. 2010 Jan;19(1):151-9. doi: 10.1517/13543780903501505. Review.

PMID:
20001560
7.

Discovery of hepatitis C virus NS5A inhibitors as a new class of anti-HCV therapy.

Lee C.

Arch Pharm Res. 2011 Sep;34(9):1403-7. doi: 10.1007/s12272-011-0921-6. Review.

PMID:
21975800
8.

Inhibition of hepatitis C virus replication by herbal extract: Phyllanthus amarus as potent natural source.

Ravikumar YS, Ray U, Nandhitha M, Perween A, Raja Naika H, Khanna N, Das S.

Virus Res. 2011 Jun;158(1-2):89-97. doi: 10.1016/j.virusres.2011.03.014. Epub 2011 Mar 31.

PMID:
21440018
9.

Antiviral treatment of hepatitis C virus infection and factors affecting efficacy.

Zhu Y, Chen S.

World J Gastroenterol. 2013 Dec 21;19(47):8963-73. doi: 10.3748/wjg.v19.i47.8963. Review.

10.

HCV796: A selective nonstructural protein 5B polymerase inhibitor with potent anti-hepatitis C virus activity in vitro, in mice with chimeric human livers, and in humans infected with hepatitis C virus.

Kneteman NM, Howe AY, Gao T, Lewis J, Pevear D, Lund G, Douglas D, Mercer DF, Tyrrell DL, Immermann F, Chaudhary I, Speth J, Villano SA, O'Connell J, Collett M.

Hepatology. 2009 Mar;49(3):745-52. doi: 10.1002/hep.22717.

PMID:
19072827
11.

Medicinal herbs for hepatitis C virus infection: a Cochrane hepatobiliary systematic review of randomized trials.

Liu J, Manheimer E, Tsutani K, Gluud C.

Am J Gastroenterol. 2003 Mar;98(3):538-44. Review.

PMID:
12650784
12.

Challenges in modern drug discovery: a case study of boceprevir, an HCV protease inhibitor for the treatment of hepatitis C virus infection.

Njoroge FG, Chen KX, Shih NY, Piwinski JJ.

Acc Chem Res. 2008 Jan;41(1):50-9. doi: 10.1021/ar700109k. Review.

PMID:
18193821
13.

HCV-hepatocellular carcinoma: new findings and hope for effective treatment.

Dash S, Haque S, Joshi V, Prabhu R, Hazari S, Fermin C, Garry R.

Microsc Res Tech. 2005 Nov;68(3-4):130-48. Review.

PMID:
16276514
14.

Resistance mutations against HCV protease inhibitors and antiviral drug design.

Shang L, Lin K, Yin Z.

Curr Pharm Des. 2014;20(5):694-703. Review.

PMID:
23688081
15.

[The molecular biology of hepatitis C virus].

Koutsoudakis G, Forns X, Pérez-Del-Pulgar S.

Gastroenterol Hepatol. 2013 Apr;36(4):280-93. doi: 10.1016/j.gastrohep.2012.11.005. Epub 2013 Mar 13. Review. Spanish.

PMID:
23490024
16.

Sofosbuvir (Sovaldi°). Active against hepatitis C virus, but evaluation is incomplete .

[No authors listed]

Prescrire Int. 2015 Jan;24(156):5-10.

PMID:
25734194
17.

Inhibitory effects of Pycnogenol® on hepatitis C virus replication.

Ezzikouri S, Nishimura T, Kohara M, Benjelloun S, Kino Y, Inoue K, Matsumori A, Tsukiyama-Kohara K.

Antiviral Res. 2015 Jan;113:93-102. doi: 10.1016/j.antiviral.2014.10.017. Epub 2014 Nov 20.

PMID:
25446333
18.

Progress in the development of anti-hepatitis C virus nucleoside and nucleotide prodrugs.

Madela K, McGuigan C.

Future Med Chem. 2012 Apr;4(5):625-50. doi: 10.4155/fmc.12.10. Review.

PMID:
22458682
19.

Boceprevir, an NS3 protease inhibitor of HCV.

Berman K, Kwo PY.

Clin Liver Dis. 2009 Aug;13(3):429-39. doi: 10.1016/j.cld.2009.05.008. Review.

PMID:
19628159
20.

Investigational drugs for hepatitis C.

Flisiak R, Parfieniuk A.

Expert Opin Investig Drugs. 2010 Jan;19(1):63-75. doi: 10.1517/13543780903431034. Review.

PMID:
20001555
Items per page

Supplemental Content

Write to the Help Desk